Ivy Leaf Extract: Combining Tradition and Science in Modern Supplements
Ivy leaf extract, derived from Hedera helix L. leaves, combines a history of traditional use with scientific research. It is recognized by the EMA for cough preparations and used in dietary supplements.
Shaanxi Ruiwo Phytochem Co., Ltd. supplies ivy leaf extract, a botanical ingredient derived from the leaves of Hedera helix L. The extract has gained recognition from the European Medicines Agency (EMA) as a component in cough preparations, highlighting its established role in health products.
The efficacy of ivy leaf extract is attributed to its complex phytochemical profile, featuring triterpenoid saponins such as hederacoside C and alpha-hederin. Hederacoside C serves as a key marker for quality control in identifying and standardizing ivy leaf materials. Research has also explored alpha-hederin's potential interactions with pathways relevant to respiratory function.
For manufacturers, selecting an ivy leaf extract involves considering botanical identity, extraction methods, and analytical consistency. The EMA's herbal monograph provides a framework for specific ivy leaf preparations, particularly for productive cough. While studies have indicated favorable outcomes for acute upper respiratory tract infections and bronchitis, ongoing research continues to evaluate the clinical significance of these findings.
Shaanxi Ruiwo Phytochem Co., Ltd. focuses on providing standardized botanical extracts that meet industry demands for quality and reliability. The company emphasizes adherence to scientific validation and regulatory standards to ensure the suitability of its ivy leaf extract for use in dietary supplements and other health-focused formulations.